Back to search
FDAFDA · Food and drugs·Recall number D-0620-2020

Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09

Published December 18, 2019 · Recall initiated: November 26, 2019

Summary

FDA records drug Class II recall D-0620-2020, published December 18, 2019 and initiated November 26, 2019. Recalling firm: SCA Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 1363 syringes; Lot: 1219012595 29-Dec-19 1219012647 01-Jan-20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals, LLC
Distributor
nationwide
Lot
1219012595 29-Dec-19 1219012647 01-Jan-20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09 recalled?

Yes. FDA published recall D-0620-2020 on December 18, 2019. Reported hazard: Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).

What should I do if I have this product?

Voluntary: Firm initiated · Letter